The Supreme Court overturned the Chevron doctrine, impacting regulatory agencies' freedom to interpret laws. CMS faces legal challenges in operationalizing the Inflation Reduction Act, particularly regarding drug price negotiation criteria.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing